Pain Medicine Doctors in Orange, CA Accepting Medicare

3 Pain Medicine doctors found. Showing 1 - 3

Dr. Standiford Helm, M.D. Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-880-7812

Calvin J. Okey, DO Pain Medicine - Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 101 The City Dr S, Uci Medical Center, Orange, CA 92868 Phone: 714-456-6369

Daniel Quoc Le, M.D. Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 280 S Main St Ste 200, Orange, CA 92868 Phone: 714-634-4567

News Archive

First meeting of WHO H1N1 response probe concludes

The first meeting of external experts tasked with reviewing the WHO's handling of the H1N1 (swine flu) virus came to a close Wednesday, with health leaders maintaining it was still too early to declare the pandemic over, Agence France-Presse reports.

Cesarean delivery is associated with an increased risk of childhood asthma hospitalization in premature infants

Cesarean delivery is associated with an increased risk of childhood asthma hospitalization in premature infants, but not in full-term infants, according to a report published in this month's Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI).

Winning the genetic body odor lottery could save on deodorant

Research shows that people who have two copies of the minor allele of a single nucleotide polymorphism found in the ABCC11 gene could save money on deodorant as they are genetically odorless.

Nanocomposite brain probe induces less scarring after implantation

A hard probe inserted in the cerebral cortex of a rat model turns nearly as pliable as the surrounding gray matter in minutes, and induces less of the tough scarring that walls off hard probes that do not change, researchers at Case Western Reserve University have found.

3D Signatures reports positive results of new Telo-HL test for Hodgkin's lymphoma

3D Signa­­­­­­tures Inc. is pleased to announce that a preliminary third-party analysis of the trial data for Telo-HL, 3DS' test in development for Hodgkin's lymphoma (HL), shows that the Company's TeloViewTM platform is able to distinguish, with a high degree of statistical significance, multiple differences between a patient group that responds to standard ABVD chemotherapy, and a group that relapses or is refractory to treatment within the first 12 months.

Read more Medical News

› Verified 6 days ago